Quince Therapeutics announces 1-for-10 reverse stock split effective April 10, 2026

Quince Therapeutics, Inc.

Approximately 16.3M shares outstanding post-split; ratio 1-for-10.
Certificate of Amendment filed with Delaware on April 9; effective 11:59 PM ET April 10.
Split-adjusted trading on Nasdaq begins at market open April 13; new CUSIP 22053A206.
Stock options and warrants proportionally adjusted; no change to rights or preferences.
Equiniti Trust Company appointed as exchange agent; fractional shares paid in cash.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.